IPO registrations (S-1, F-1) · Registrants
Krystal Biotech, Inc.
- SEC CIK
- 1711279 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2017-08-21, last 2017-09-14; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2017-09-20; declared effective 2017-09-19
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Business address
- 2100 WHARTON STREET, SUITE 701, Pittsburgh, PA 15203
- EIN
- 82-1080209
- Ticker
- KRYS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Krystal Biotech, Inc. on the corporate pages
Offering terms
- Proposed price range
- $9.00–$11.00 per share (S-1/A filed 2017-09-14)
- Final price
- $10.00 per share, within the range (424B4 filed 2017-09-20, an initial public offering)
- Shares sold
- 3,960,000
- Gross proceeds
- $39,600,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol KRYS
- Lead underwriters
- Ladenburg Thalmann (3,960,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: KRYSTAL BIOTECH, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Krystal Biotech, Inc. Fuzzy (name and state)
- Business registration: Krystal Biotech, Inc. Fuzzy (name and state)
- Business registration: Krystal Biotech, Inc. Fuzzy (name and state)
- Business registration: Krystal Biotech, Inc. Fuzzy (name and state)
- Business registration: KRYSTAL BIOTECH, INC. Fuzzy (name and state)
- Business registration: KRYSTAL BIOTECH, INC. Fuzzy (name and state)
- Business registration: KRYSTAL BIOTECH, INC. Fuzzy (name and state)
- Business registration: KRYSTAL BIOTECH, INC. Fuzzy (name and state)
- Business registration: KRYSTAL BIOTECH, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: KRYSTAL BIOTECH, INC. EXACT (EIN (EXACT))
- Federal award recipient: KRYSTAL BIOTECH, INC. Fuzzy (name and state)
- Form D issuer: Krystal Biotech, Inc. EXACT (CIK (EXACT))
- SEC filer: Krystal Biotech, Inc. EXACT (CIK (EXACT))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2017-08-21 | S-1 | S-1 (registration) | Krystal Biotech, Inc. | 0001193125-17-263771 ↗ |
| 2017-09-07 | S-1/A | S-1/A (amendment) | Krystal Biotech, Inc. | 0001193125-17-278107 ↗ |
| 2017-09-14 | S-1/A | S-1/A (amendment) | Krystal Biotech, Inc. | 0001193125-17-285053 ↗ |
| 2017-09-19 | S-1MEF | S-1MEF (added securities) | Krystal Biotech, Inc. | 0001193125-17-288531 ↗ |
| 2017-09-19 | EFFECT | EFFECT (declared effective) | Krystal Biotech, Inc. | 9999999995-17-002397 ↗ |
| 2017-09-20 | 424B4 | 424B4 (final prospectus) | Krystal Biotech, Inc. | 0001193125-17-289035 ↗ |
| 2018-10-12 | EFFECT | EFFECT (declared effective) | Krystal Biotech, Inc. | 9999999995-18-002613 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-09-14 | S-1/A | registration statement | $9.00–$11.00 | 3,000,000 | - | Nasdaq KRYS | 1 | primary document; range, shares headline, cover names 1 | document ↗ | |
| 2017-09-20 | 424B4 | final prospectus | $10.00 | 3,960,000 | $39,600,000 | Nasdaq KRYS | 1 | primary document; price sentence, shares headline, proceeds table, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Ganorkar Kirti | Director | 1 | 2017 | ||
| JANNEY DANIEL | Director | 20 | 2017–2026 | ||
| Krishnan Krish S | Director,Officer,TenPercentOwner | President and CEO | 39 | 2017–2026 | |
| Krishnan Suma | Director,Officer,TenPercentOwner | Chief Operating Officer; President, R&D | 40 | 2017–2026 | |
| NORBY R DOUGLAS | Director | 4 | 2017–2018 | ||
| ROSSI DINO A | Director | 15 | 2017–2026 | ||
| Sun Pharma (Netherlands) B.V. | TenPercentOwner | 2 | 2017 | ||
| Riley Antony A | Officer | Chief Financial Officer | 5 | 2018–2019 | |
| Gangolli Julian S | Director | 10 | 2019–2026 | ||
| Chien Jennifer | Officer | Chief Commercial Officer | 2 | 2020 | |
| Romano Kathryn | Officer | Chief Accounting Officer | 13 | 2020–2026 | |
| Marantz Jing L. | Director; Officer | Chief Business Officer | 4 | 2021–2022 | |
| Mason Christopher | Director | 8 | 2021–2026 | ||
| ORTH ANDREW C. | Officer | Chief Commercial Officer | 5 | 2021–2023 | |
| Sutherland Everett Rand | Director | 7 | 2022–2026 | ||
| Mazzacco Catherine | Director | 6 | 2023–2026 | ||
| Goux Laurent Louis Jean | Officer | EVP, Head of International | 1 | 2026 | |
| Thomas John Charles | Officer | EVP, General Counsel | 3 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-08-18 | Krystal Biotech, Inc. | Biotechnology | $11,254,534 | $11,254,534 | 16 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Krystal Biotech, Inc. | PA | State business registries | name and state |
| Business registration | Krystal Biotech, Inc. | PA | State business registries | name and state |
| Business registration | Krystal Biotech, Inc. | PA | State business registries | name and state |
| Business registration | Krystal Biotech, Inc. | PA | State business registries | name and state |
| Business registration | KRYSTAL BIOTECH, INC. | PA | State business registries | name and state |
| Business registration | KRYSTAL BIOTECH, INC. | PA | State business registries | name and state |
| Business registration | KRYSTAL BIOTECH, INC. | PA | State business registries | name and state |
| Business registration | KRYSTAL BIOTECH, INC. | PA | State business registries | name and state |
| Business registration | KRYSTAL BIOTECH, INC. | PA | State business registries | name and state |
| Business registration | KRYSTAL BIOTECH, INC. | PA | State business registries | name and state |
| Plan sponsor | KRYSTAL BIOTECH, INC. | PA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | KRYSTAL BIOTECH, INC. | PA | Federal spending (USAspending) | name and state |
| Form D issuer | Krystal Biotech, Inc. | PA | Form D private offerings | CIK (EXACT) |
| Paying company | Krystal Biotech Inc | PA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Krystal Biotech, Inc. | PA | Patents (USPTO) | name and state |
| SEC filer | Krystal Biotech, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Krystal Biotech, Inc. | PA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | KRYSTAL BIOTECH, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), PA first:
- APOLLON INC PA
- Aevi Genomic Medicine, LLC PA
- Ocugen, Inc. PA
- Spark Therapeutics, Inc. PA
- Cabaletta Bio, Inc. PA
- Passage BIO, Inc. PA
- Century Therapeutics, Inc. PA
- Aphton CORP PA
- Aceragen, Inc. PA
- GENAERA CORP PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health